American Society of Addiction Medicine
American Society of Addiction Medicine
Lead: Piloting a Hospital-Based Rapid Methadone Initiation Protocol for Fentanyl
Lead: Piloting a Hospital-Based Rapid Methadone Initiation Protocol for Fentanyl
Lead: Piloting a Hospital-Based Rapid Methadone Initiation Protocol for Fentanyl
Tuesday 18th June 2024
Explore rapid methadone initiation for fentanyl, naloxone distribution benefits, rising drug-related infant mortality, and more in addiction medicine.
6 minutes
Informative
Compassionate
Educational
Supportive
Engaging
About this podcast
Author:
American Society of Addiction Medicine
Overview:
Categories:
Innovative Treatments & Recovery Paths
Navigating Alcohol Dependency
Family Recovery from Addiction
Nutritional Pathways to Recovery
Navigating Intimate Relationships
Links:
Visit site
Episodes:
140 (View all)
Do you want to link to this podcast?
Get the buttons here!Rapid Methadone Protocols and More: Key Updates in Addiction Medicine
Episode Overview
- Rapid methadone initiation shows promise for treating opioid use disorder.
- Enhanced naloxone distribution could significantly reduce overdose deaths.
- Rising drug-related infant mortality highlights need for public health interventions.
- Maternal cannabis use disorder linked to higher autism risk in offspring.
- Routine screening for cannabis use in primary care is essential.
You have only one responsibility, sell baby sell
In this episode of 'This Week in Addiction Medicine from ASAM', you'll dive into the latest research and studies impacting the field of addiction medicine. The lead story focuses on a groundbreaking hospital-based rapid methadone initiation protocol for fentanyl, aiming to address the increased opioid tolerance due to the fentanyl epidemic. The study highlights a structured dosing regimen and its promising results, with no adverse events reported among the participants.
This could be a game-changer for treating opioid use disorder in an inpatient setting. Another study discussed explores the potential benefits of enhanced community-based naloxone distribution, supported by an opioid settlement. The findings suggest that optimised naloxone distribution could significantly reduce annual opioid overdose deaths. The episode also touches on the alarming rise in drug-related infant mortality in the United States, stressing the need for comprehensive public health interventions.
Further, the episode covers a study linking maternal cannabis use disorder with an increased risk of autism spectrum disorder in offspring, based on data from New South Wales, Australia. The podcast also delves into cannabis use among primary care patients, revealing a high prevalence of use for symptom management and the need for routine screening. Listeners will also learn about functional connectivity changes in the brains of adolescents with internet addiction, and how these changes affect their behaviour and development.
Additionally, the episode discusses genetic variants associated with acamprosate treatment response in patients with alcohol use disorder, paving the way for more personalised treatment approaches. The final segment exposes questionable marketing practices by an opioid giant, highlighting the importance of ethical standards in medical marketing. This episode is packed with valuable information and insights that can help healthcare professionals stay informed and make better decisions in addiction medicine.
Don't miss out on these crucial updates and studies that could shape the future of addiction treatment.